Saba Capital Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Saba Capital Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-210,576	Closed	-$50.7K	–	511
2023 Q4	$50.7K	Hold	210,576	–	–	﹤0.01%	323
2023 Q3	$73.5K	Hold	210,576	–	–	﹤0.01%	355
2023 Q2	$35.8K	Hold	210,576	–	–	﹤0.01%	442
2023 Q1	$30.6K	Hold	210,576	–	–	﹤0.01%	594
2022 Q4	$14.7K	Hold	210,576	–	–	﹤0.01%	769
2022 Q3	$7K	Hold	210,576	–	–	﹤0.01%	1036
2022 Q2	$26K	Hold	210,576	–	–	﹤0.01%	974
2022 Q1	$38K	Sell	210,576 -39,500	-16%	-$9.99K	﹤0.01%	894
2021 Q4	$80K	Buy	+250,076	New	+$79.1K	﹤0.01%	710

Saba Capital Management's DMAQR Position: Q1 2024 in Review

Saba Capital Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 210,576 shares — an estimated $50.7K sold.

Saba Capital Management first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $80K in Q4 2021. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Saba Capital Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Saba Capital Management sold 210,576 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $50.7K.
Saba Capital Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
Saba Capital Management's Deep Medicine Acquisition Corp. Rights position peaked at $80K in Q4 2021.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Saba Capital Management's 13F filing for Q1 2024, filed 15 May 2024.